Featured Product

    IOSCO Consults on Policy Measures for OTC Leveraged Products

    February 13, 2018

    IOSCO issued a consultation report that proposes policy measures to consider when addressing the risks arising from the offer and sale of OTC leveraged products to retail clients. The report on retail OTC leveraged products identifies various regulatory approaches aimed to enhance the protection of retail investors who are offered OTC leveraged products, often on a cross-border basis. The report covers the offer and sale by intermediaries of rolling-spot forex contracts, contracts for differences (CFDs), and binary options. Comments on the consultation report must be submitted on or before March 27, 2018.

    IOSCO proposes the following policy measures in the report and offers guidance to regulators on how to apply each one:

    • A licensing requirement for all firms that sell the relevant products to retail investors either domestically or on a cross-border basis
    • Leverage limits or minimum margin requirements
    • Measures to address the risk of investors losing more than their initial investment
    • Measures to enhance the disclosure of costs and charges of the products
    • Measures to improve the disclosure of risks of the products, including profit and loss ratios
    • Other focused requirements to enhance the quality of pricing and order execution
    • Measures to restrict the sale, distribution, and marketing of the products with a view to addressing mis-selling risk

    Intermediaries market and sell these products to retail investors in most IOSCO member jurisdictions. In its report, IOSCO encourages its members to improve the practices of licensed firms that offer OTC leveraged products, in an effort to better inform investors about the features and risks of these products and to more effectively combat illegal cross-border activity in this area. This consultation report is part of the ongoing work of IOSCO on retail investor protection. In December 2016, IOSCO had published a fact-finding report titled "Report on the IOSCO Survey on Retail OTC Leveraged Products" that describes the main risks, activities, and participants in this retail OTC market segment. The current consultation is part of a wider IOSCO mandate, which will also include policy proposals and guidance regarding investor education material on relevant products and firms, along with the enforcement approaches and practices to address the risks posed by unlicensed firms operating in this area. IOSCO is seeking feedback on the tools and measures proposed in this report.

     

    Related Links

    Comment Due Date: March 27, 2018

    Keywords: International, Securities, OTC Leveraged Products, Customer Protection, IOSCO

    Related Articles
    News

    PRA Guides Further on Treatment of Payment Deferrals in CRR and IFRS 9

    PRA published a "Dear CEO" letter from Sam Woods, its Deputy Governor and CEO, to update the March guidance on treatment of COVID-19-related payment deferrals under IFRS 9 and the Capital Requirements Regulation (CRR).

    June 04, 2020 WebPage Regulatory News
    News

    MAS Announces Additional Relief Measures Amid COVID Crisis

    MAS, along with the Ministry of Finance (MOF), the Inland Revenue Authority of Singapore (IRAS), and the Enterprise Singapore (ESG), announced a package of measures to support those that may face cash-flow constraints.

    June 03, 2020 WebPage Regulatory News
    News

    ESMA Consults on Guidelines for Cloud Outsourcing

    ESMA published a consultation paper on guidelines on outsourcing to cloud service providers.

    June 03, 2020 WebPage Regulatory News
    News

    EBA to Release Data for 2020 Spring Transparency Exercise Next Week

    EBA announced that it will release the bank-by-bank data of the Spring 2020 EU-wide transparency exercise on Monday, June 8.

    June 02, 2020 WebPage Regulatory News
    News

    PRA Issues Statement on Use of E-Signatures to Submit Regulatory Forms

    PRA issued a statement confirming that firms may use electronic signatures for submission of forms and other regulatory documents, although in specific instances PRA may request a "wet signature" where it is appropriate to do so.

    June 02, 2020 WebPage Regulatory News
    News

    EBA to Require Additional Reporting and Disclosures for COVID Measures

    EBA published the guidelines and templates for reporting and disclosure of exposures subject to measures applied in response to the COVID-19 crisis.

    June 02, 2020 WebPage Regulatory News
    News

    FCA Guidance Confirms Support for Mortgage Customers Amid Crisis

    FCA updated its guidance confirming the support firms should give to mortgage customers that are either coming to the end of a payment holiday or are yet to request one.

    June 02, 2020 WebPage Regulatory News
    News

    US Agencies Temporarily Amend Supplementary Leverage Ratio Calculation

    US Agencies (FDIC, FED, and OCC) published an interim final rule that temporarily revises the supplementary leverage ratio calculation for depository institutions.

    June 01, 2020 WebPage Regulatory News
    News

    APRA FAQ for Standard on Margins for Non-Centrally Cleared Derivatives

    APRA published a frequently asked question (FAQ) providing guidance to all APRA-regulated entities in determining their requirements under the prudential standard CPS 226 on margins and risk mitigation for non-centrally cleared derivatives.

    June 01, 2020 WebPage Regulatory News
    News

    EBA Proposes Revised Standards for Own Funds and Eligible Liabilities

    EBA published a consultation paper on the draft amended regulatory technical standards on own funds and eligible liabilities.

    May 29, 2020 WebPage Regulatory News
    RESULTS 1 - 10 OF 5253